Loading data for VRDN — first visit, this takes a few seconds.

提醒

Viridian Therapeutics Inc... (VRDN)

NasdaqCM: VRDN · 即時價格 · USD

23.88

-0.38 (-1.57%)

收盤價： Aug 28, 2026, 3:59 PM

23.41

-1.97%

盤後: 7:30 PM

股價、關鍵數字和最新消息，都在這一頁。

-1.57% (1D)

買價	17.59
市值	2.71B
營收 (ttm)	71.13M
淨利（ttm）	-334.03M
	0.94
	-3.4
	n/a
	-8.61
P/B (ttm)	4.85
P/S (ttm)	38.04
財報日期	Nov 5, 2026

賣價	30.86
成交量	839,634
20 日平均成交量	1,943,795
開盤價	24.22
前收盤價	24.26
當日區間	23.75 - 24.47
52 週範圍	13.18 - 34.29
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 VRDN

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TS...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Jun 18, 2014

員工 252

證券交易所 NasdaqCM

股票代號 VRDN

網站 https://www.viridiantherapeutics.com

完整的公司簡介

財務表現

Viridian Therapeutics 在 2025 年的營收為 70.85M，較前一年的 302K 增加 23,359.93%。淨利為 -342.6M，較前期增加 26.91%。

財務報表

財報驚奇

Viridian Therapeutics 已於 Aug 6, 2026 公布季度財報：

營收為 $284K 低於預期 $0, 年增 278.67% 成長.
每股盈餘為 -1.05 低於預期 -0.02, 年增 -5.00% 下滑.

下次財報發布

Viridian Therapeutics Inc. 的下次財報預計於 Nov 5, 2026, 開盤前。
分析師預估營收 ... 升級

新聞動態

3 週前 · MT Newswires

Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says

Viridian Therapeutics (VRDN) is set to see "minimal" revenue growth in H2 before inflecting meaningf

1 月前 · Insider Monkey

Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the 10 affordable biotech stocks to buy right now. On June 30, Goldman Sachs increased its target price for Viridian Therapeutics Inc. (NASDAQ:VRDN) ...

1 月前 · Simply Wall St.

Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich?

Viridian Therapeutics (VRDN) has drawn fresh investor attention after recent trading left the stock at $19.08. Recent performance has been mixed across different periods, and the company’s business re...

1 月前 · Simply Wall St.

Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today

Viridian Therapeutics stock has fallen 37.8% year to date, yet the valuation checks still point to the shares looking expensive rather than like a clear bargain. The year to date decline of 37.8% rais...

1 月前 · TipRanks

“Stay Invested”: Wells Fargo Picks 2 Stocks to Buy as It Stays Bullish on the Market

What to make of the markets today? The biggest story in recent months has been the conflict in the Middle East and its effect on oil prices. After pulling back for a while, crude has started moving hi...

第 1 頁，共 2 頁

Viridian Therapeutics Inc... (VRDN)